“It is time we pool our best efforts to critically interrogate the existing data and generate new in vitro data to identify the most promising combination therapies for animal studies to proceed to human trials.”

Francoise Barre-Sinoussi, PhD (2008 Nobel Prize Medicine) and Jintanat Ananworanich, MD, PhD
— "Is it time to abandon single intervention cure trials?" published in The Lancet HIV, October 2015

CureGrail’s mission is connecting biology, engineering and mathematics;

Collaborating with and delivering transformative technology
to research and scientific partners;

Finding fast paths to success with combination therapy
for seemingly incurable diseases.

Our purpose is to save and enrich lives.

Find out more about who we are, what we do, our methods, and the results of our decades of experience.